Study

A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder. – Cost Effective Supplements

A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/22864465


Conclusion of this study

The current study suggests that creatine augmentation of SSRI treatment may be a promising therapeutic approach that exhibits more rapid and efficacious responses in women with major depressive disorder.


Supplements analyzed in this study

Creatine

Health conditions analyzed in this study

Depression


Moderately Positive
Creatine


Functions related to this study

Emotional health


Moderately Positive
Creatine


Body systems related to this study


Nervous System
Scroll to top